Discover 1,955 paid clinical trials in Plano, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,955
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
for
Lung Neoplasm
Location: Dallas TX, Lexington KY, Fairfax VA, Baltimore MD
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06780098
Phase 2, Recruiting
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
for
Non-Small-Cell Lung Cancer,
Location: Dallas TX, Houston TX, Aurora CO, Arlington Heights IL,
Sponsor: ArriVent BioPharma, Inc.
Sex: All
Age: 18+
Code: NCT07185997
Phase 3, Recruiting
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
for
Ovarian Neoplasms, Breast Neoplasms,
Location: Dallas TX, St Louis MO, Indianapolis IN, Rochester MN,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213791
Phase 1, Recruiting
Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)
for
Pancreatic Adenocarcinoma
Location: Dallas TX
Sponsor: Baylor Research Institute
Sex: All
Age: 18+
Code: NCT04926467
Phase 2, Recruiting
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
for
Coronary Artery Disease
Location: Dallas TX, Kyle TX, Wichita KS, St Louis MO,
Sponsor: Teleflex
Sex: All
Age: 18+
Code: NCT06779630
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Dallas TX, Tyler TX, San Antonio TX, Baton Rouge LA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06943872
Phase 3, Recruiting
Analysis of Graft Function Following Autologous Islet Transplantation
for
Chronic Pancreatitis
Location: Dallas TX
Sponsor: Baylor Research Institute
Sex: All
Age: 18+
Code: NCT03097185
Recruiting
UTSW NORC Pilot Spinal Cord Injury Dietary Program
for
Obesity and Obesity-related Medical Conditions,
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18 - 65
Code: NCT06924177
Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18 - 70+
Code: NCT06489483
Recruiting
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
for
Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell,
Location: Dallas TX, Nashville TN, Denver CO, Atlanta GA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07226843
Phase 1, Recruiting
Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes
for
Heart Failure, Diabetes
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 0+
Code: NCT06593314
Recruiting
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
for
HR+/HER2- Breast Cancer
Location: Dallas TX, Round Rock TX, Austin TX, Hot Springs AR,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07492641
Phase 3, Recruiting
The Role of Sirolimus in Preventing Functional Decline in Older Adults
for
Aging
Location: Dallas TX
Sponsor: Irina Timofte
Sex: All
Age: 65 - 70+
Code: NCT05237687
Phase 2, Recruiting
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Escitalopram in Asthma Patients With Frequent Exacerbation
for
Asthma
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18 - 70+
Code: NCT06216535
Phase 2, Recruiting
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
for
Colorectal Cancer
Location: Grapevine TX, Fort Worth TX, Austin TX, Houston TX,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07023289
Phase 2, Recruiting
Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)
for
Non-Small Cell Lung Cancer
Location: Dallas TX, Beaumont TX, San Antonio TX, St Louis MO,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07680790
Phase 3, Recruiting
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
for
Non-Small Cell Lung Cancer, c-MET
Location: Dallas TX, Tyler TX, Little Rock AR, Lincoln NE,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06568939
Phase 2, Recruiting
Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
for
Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC),